We present a case of gastrointestinal bleeding due to antiplatelet therapy
after percutaneous coronary intervention (PCI) and secondary in-stent thrombosis due to discontinuation of antiplatelet drugs.
031/18-EA Lot 1 "Reagents for the monitoring system of antiplatelet therapy
on whole blood" Multiplate "(closed-type analyzer) for the Grodno regional clinical cardiological center.
PPIs may be beneficial in preventing upper GI bleeds in patients taking dual warfarin and antiplatelet therapy
, but the long-term consequences of PPI therapy should not be ignored.
The comprehensive new version reflects current best practices for using aspirin combined with P2Y12 receptor inhibitors clopidogrel, prasugrel or ticagrelor, and includes a review of 11 studies of patients treated with coronary stent implantation done predominately with drug-eluting stents to assess the risks and benefits of shorter-versus longer-duration dual antiplatelet therapy
Patients who are diagnosed with atrial fibrillation (AFib), an irregular and sometimes very rapid heartbeat, have a higher risk of developing dementia if they are not treated with the anticoagulant medication warfarin (Coumadin) or with antiplatelet therapy
within 30 days of diagnosis, according to a study presented at the Heart Rhythm Society 2017 Scientific Sessions.
Preoperative chronic anticoagulation or antiplatelet therapy
has led to an increased risk for postoperative SSH, however, which was not statistically significant.
The multinational, randomised phase 3b study will assess a treatment regimen based on the company's oral, once-daily direct factor Xa-inhibitor, edoxaban, against a vitamin K antagonist based regimen, with or without antiplatelet therapy
, in patients with atrial fibrillation following successful transcatheter aortic valve implantation.
His presentation was mainly based on the American College of Cardiology/American Heart Association 2016 Guidelines on dual antiplatelet therapy
We present a unique case report of two-vessel subacute stent thrombosis in a patient receiving clopidogrel as part of dual antiplatelet therapy
after PCI with DES.
have high chances of bleeding when there is concurrent use of antiplatelet therapy
Patients at greatest risk are those taking aspirin plus clopidogrel (dual antiplatelet therapy
, or DAPT), for whom adding an NSAID increases the risk of a cardiovascular event 159 percent.
Unmet medical needs for actionable genomic, functional and pharmaco-responsiveness information about platelets continues to grow and are fueled by the expanding role of antiplatelet therapy
, including dual and triple antiplatelet therapy